PAFR in adipose tissue macrophages is associated with anti-inflammatory phenotype and metabolic homeostasis

Clinical Science
Luciano R FilgueirasFrancisco J Rios

Abstract

Metabolic dysfunction is associated with adipose tissue inflammation and macrophage infiltration. The Platelet Activating Factor Receptor (PAFR) is expressed in several cell types and binds to PAF and oxidized phospholipids. Engagement of PAFR in macrophages drives them towards the anti-inflammatory phenotype. In the present study, we investigated whether genetic deficiency of PAFR affects the phenotype of adipose tissue macrophages (ATM) and its effect on glucose and insulin metabolism. PAFR-deficient (PAFRKO) and wild type mice (WT) were fed standard (SD) or high fat diet (HFD). Glucose and insulin tolerance tests were performed by blood monitoring. ATM were evaluated by FACS for phenotypic markers. Gene and protein expression was investigated by real-time PCR and western-blot, respectively. Results showed that the epididymal adipose tissue of PAFRKO mice had increased gene expression of Ccr7, Nos2, Il6, and Il12, associated topro-inflammatory mediators, and reduced expression of the anti-inflammatory IL10 . Moreover, the adipose tissue of PAFRKO presented higher pro-inflammatory macrophages, characterized by an increased frequency of F4/80(+)CD11c(+) cells. Blood monocytes of PAFRKO mice also exhibited a pro-inflammatory phe...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Satoshi IshiiTakao Shimizu
Sep 15, 2004·Circulation·Husam GhanimParesh Dandona
Dec 13, 2005·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Feb 8, 2006·Annual Review of Physiology·Sudha B Biddinger, C Ronald Kahn
Jan 4, 2007·The Journal of Clinical Investigation·Carey N LumengAlan R Saltiel
Nov 26, 2008·Nature Reviews. Immunology·David M Mosser, Justin P Edwards
Dec 10, 2009·The Journal of Experimental Medicine·Daniel J WestcottCarey N Lumeng
Jul 28, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alessandra A FilardyGeorge A DosReis
Dec 3, 2010·The New England Journal of Medicine·Amy Berrington de GonzalezMichael J Thun
Jul 12, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew SpiteBodduluri Haribabu
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jenny E KanterKarin E Bornfeldt
Oct 9, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Junko SugataniTakao Shimizu
Jan 1, 2010·The Open Endocrinology Journal·M L GolsonM Gannon
Jul 23, 2014·The Journal of Investigative Dermatology·Matheus FerraciniJeffrey B Travers
Oct 11, 2014·Endocrine·Ana Lúcia CecconelloMaria Flávia Marques Ribeiro
Jan 30, 2015·Science Signaling·Luciano Ribeiro FilgueirasC Henrique Serezani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.